exp3174 has been researched along with l 692429 in 1 studies
| Studies (exp3174) | Trials (exp3174) | Recent Studies (post-2010) (exp3174) | Studies (l 692429) | Trials (l 692429) | Recent Studies (post-2010) (l 692429) |
|---|---|---|---|---|---|
| 236 | 29 | 43 | 40 | 5 | 1 |
| Protein | Taxonomy | exp3174 (IC50) | l 692429 (IC50) |
|---|---|---|---|
| Growth hormone secretagogue receptor type 1 | Rattus norvegicus (Norway rat) | 0.06 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 3.6 | |
| Growth hormone secretagogue receptor type 1 | Homo sapiens (human) | 2.8 | |
| Growth hormone secretagogue receptor type 1 | Sus scrofa (pig) | 0.063 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schieffer, B; Schmidt, B | 1 |
1 review(s) available for exp3174 and l 692429
| Article | Year |
|---|---|
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Growth Hormone; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Models, Molecular; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Thromboxane A2 | 2003 |